Growth Metrics

ImmunityBio (IBRX) Net Income towards Common Stockholders (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -921.33%
Dec 31, 2025 7.90%
Sep 30, 2025 27.35%
Jun 30, 2025 28.60%
Mar 31, 2025 -119.17%
Dec 31, 2024 30.99%
Sep 30, 2024 36.28%
Jun 30, 2024 -0.34%
Mar 31, 2024 42.54%
Dec 31, 2023 -144.05%
Sep 30, 2023 30.80%
Jun 30, 2023 -18.55%
Mar 31, 2023 -7.62%
Dec 31, 2022 2.55%
Sep 30, 2022 -17.22%
Jun 30, 2022 7.93%
Mar 31, 2022 -12.50%
Dec 31, 2021 -3.53%
Sep 30, 2021 1.07%
Jun 30, 2021 -11.06%
Mar 31, 2021 -17.37%
Dec 31, 2020 -3.63%
Sep 30, 2020 -27.21%
Jun 30, 2020 -38.98%
Mar 31, 2020 65.98%
Dec 31, 2019 -606.05%
Sep 30, 2019 6.60%
Jun 30, 2019 6.73%
Mar 31, 2019 -123.36%
Dec 31, 2018 424.00%
Sep 30, 2018 14.77%
Jun 30, 2018 -0.77%
Mar 31, 2018 -12.38%
Dec 31, 2017 -2.16%
Sep 30, 2017 -2.20%
Jun 30, 2017 4.34%
Mar 31, 2017 -1.14%
Dec 31, 2016 24.01%
Sep 30, 2016 6.18%
Jun 30, 2016 -10.82%
Mar 31, 2016 -114.70%
Dec 31, 2015 550.48%
Sep 30, 2015 64.62%
Jun 30, 2015 -298.47%
Mar 31, 2015 -1,101.06%
Dec 31, 2014 -205.25%
Sep 30, 2014 35.82%
Jun 30, 2014 -69.01%